Elliot Gershon to Neuropsychological Tests
This is a "connection" page, showing publications Elliot Gershon has written about Neuropsychological Tests.
Connection Strength
0.246
-
White Matter, Cognition, and Electrophysiological Variables in Bipolar Disorder: Using Multimodal Integration of Biomarker Variables Associated With Bipolar Disorder to Elucidate Deficits. Bipolar Disord. 2025 May; 27(3):205-216.
Score: 0.048
-
Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders. Schizophr Res. 2023 05; 255:69-78.
Score: 0.042
-
Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022 03 08; 113:110464.
Score: 0.038
-
The association between lithium use and neurocognitive performance in patients with bipolar disorder. Neuropsychopharmacology. 2020 09; 45(10):1743-1749.
Score: 0.034
-
VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Transl Psychiatry. 2018 10 11; 8(1):215.
Score: 0.031
-
Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018 04 12; 8(1):78.
Score: 0.030
-
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry. 2013 Nov; 170(11):1275-84.
Score: 0.022